Story
Terawulf Stock Declines on Market Weakness and Insider Selling Concerns

Summary
Shares of the digital asset infrastructure company fell amid a wider market downturn, pressured by recent executive stock sales and a lack of fresh positive catalysts.
Shares of Terawulf (NASDAQ: WULF) fell 3.5% in morning trading, hitting an intraday low of $15.17 as a broad market sell-off combined with company-specific pressures to weigh on the stock.
Broad Market Headwinds
The decline occurred amid a widespread risk-off tone on Wall Street that disproportionately affected growth and technology stocks. The tech-heavy Nasdaq Composite fell 1.3%, while the S&P 500 declined 1.0%.
This negative macro environment triggered a pullback in high-beta sectors, including AI infrastructure and digital asset companies. According to the source, Terawulf has been caught in this sector-wide consolidation after a strong multi-week run, and it remains well off its 52-week high of $29.84.
Insider Sales and Analyst Sentiment
Investor sentiment continues to be affected by a persistent overhang from recent insider stock sales. Filings from August 31 show significant sales by top executives:
Ad- CEO Paul B. Prager sold 137,500 shares for approximately $2.35 million.
- Director Walter E. Carter sold 130,626 shares for roughly $1.98 million.
A subsequent Form 144 filing, which signals an insider's intent to sell additional restricted securities, has kept investors cautious about near-term supply pressure on the stock.
Muted Impact from New Coverage
Recent analyst actions have failed to provide a positive catalyst. While Jones Trading initiated coverage with a Buy rating and a $30 price target, this did not surprise the market, which already has 23 existing Buy ratings on the company.
Conversely, a recent Neutral initiation from Rothschild & Co Redburn with a $15 price target has served as a sentiment anchor, as the target was set below where the stock had been trading. The combination of these factors has contributed to the day's decline, even as the long-term analyst consensus remains bullish.
Read next
More on Stocks
Roth/MKM Initiates Buda Juice With 'Buy' Rating, Sets $12 Target on Retail Growth
Roth/MKM has started coverage on beverage producer Buda Juice with a Buy rating and a $12 price target, citing the company's potential to expand its retail footprint following its recent IPO.

Evonik Rejects BASF's €10.3 Billion Takeover Bid as Too Low, Sources Say
The German specialty chemicals firm has reportedly turned down an offer valued at €22.15 per share from rival BASF, according to sources familiar with the matter. The rejection sent Evonik's shares higher while BASF has stated it is taking a 'disciplined approach' to the potential deal.

Carvana Stock Declines Amid Regulatory Scrutiny and Market-Wide Sell-Off
Shares of the online auto retailer fell sharply, pressured by a combination of unresolved federal investigations and a broader risk-off sentiment across U.S. equity markets.

Turkish Stocks Fall to Six-Month Low as BIST 100 Index Drops 2.38%
Turkey's benchmark BIST 100 index fell 2.38% to a new six-month low on Monday, driven by broad-based losses across multiple sectors including leasing, machinery, and sports.